Caas Capital Management LP Cure Vac N.V. Transaction History

Caas Capital Management LP

  • $552 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$6.38 - $12.5 $684,593 - $1.34 Million
107,303 New
107,303 $747,000
Q2 2021

Aug 16, 2021
SELL
$56.91 - $127.53 $8.12 Million - $18.2 Million
-142,633 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$79.79 - $126.29 $11.4 Million - $18 Million
142,633 New
142,633 $13 Million

Others Institutions Holding CVAC

# of Institutions
86
Shares Held
10.5M
Call Options Held
75.5K
Put Options Held
33.5K
View Full List

About CureVac N.V.

CVAC Quotes by TradingView
  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $617M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email